An epidemiological study for treat-to-target strategy in rheumatoid arthritis patients with moderate or high disease activity
Not Applicable
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000006701
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 366
Inclusion Criteria
Not provided
Exclusion Criteria
A patient who has any of the following will be excluded from our study. 1.When a patient withdraws his or her consent. 2.When a doctor judges a patient is not appropriate to join the study. 3.When a patient is under breastfeeding or pregnant. 4.When a doctor judges a patient cannot be followed regularly in the outpatient clinic for 72 weeks.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome for our study is to identify prognostic factors for physical function and structural damage at week 72 in RA patient with moderate or high disease activity who receive treatment with T2T strategy. The main outcome measures are SDAI, CDAI, HAQ, EQ-5D and vdH-modified Total Sharp Score. We compare these outcome measures between the T2T-achieved group and not-achieved group.
- Secondary Outcome Measures
Name Time Method 1.Remission or Low disease activity status achievement rates in clinical practice 2.Implementation rate of T2T 3.Obstacles for implementation of T2T strategy